MissionIR Articles
-
MissionIRNewsBreaks – Brain Scientific Inc. (BRSF) Solution Holds Ability to Bridge the Gap in Neuro Testing
Brain Scientific (OTCQB: BRSF) is focused on modernizing brain diagnostics through cutting-edge technologies. The company’s NeuroCap(TM) offers a cost-effective, disposable solution that has the ability to bridge the gap in access to neurological testing. A…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Announces Participation in Upcoming Investor Conferences
Trxade Group (NASDAQ: MEDS), a technology-enabled health services platform company focused on digitalizing the retail pharmacy experience, will be participating in three investor conferences scheduled in March 2021. In all three conferences, Trxade Group CEO Suren Ajjarapu will…
-
Brain Scientific Inc. (BRSF) Making EEGs Accessible in Emergency Departments
Head CTs, MRIs are most-used but not most-effective tool for head trauma or neurological issues in triage EEG changed clinical management of 76.2% of patients, even when CT or MRI was available Brain Scientific has…
-
Predictive Oncology Inc. (NASDAQ: POAI) Announces Fundraising Agreements to Raise Estimated $25M
POAI completes two separate fundraising initiatives: private placement, direct offering. Two fundraising campaigns expected to result in $17.6 million, $7.4 million respectively. Predictive Oncology plans to use funds to pay off debt as well as…
-
Uranium Energy Corp. (NYSE American: UEC) Positioned Favorably to Capitalize on Rising Uranium Demand
Increased nuclear power projects fueling rising demand for uranium UEC controls one of the largest historical uranium exploration and development databases in United States UEC property portfolio includes properties previously explored and developed by senior…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) and WPD Pharmaceuticals (CSE: WBIO) (Frankfurt: 8SV1) Get the Green Light for Clinical Trials’ Protocols from Ethics Panels
CNS Pharmaceuticals holds the exclusive worldwide license to the Berubicin chemical compound Berubicin is CNSP’s lead, novel anthracycline candidate for the treatment of glioblastoma multiforme (“GBM”) that was the subject of a previously conducted Phase…
-
MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Reaches Milestone: Ladenburg Thalmann & Co. Inc. Signs Market Maker Intention Letter
Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on generating shareholder value by incubating innovative products into mature and dominant brands within their respective markets, has met a significant requirement in the process of uplisting…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Stephens Best Ideas Conference
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, has been selected to participate in the virtual Stephens 2021 Best Ideas Conference. The conference is slated for March 11, 2021. As part…
-
MissionIRNewsBreaks – Augusta Gold Corp. (OTCQB: AUGG) (CSE: G) (FSE: 11B) Announces Closing of Private Placement, Gross Proceeds Total C$17 Million
Augusta Gold Corp.(OTCQB: AUGG) (CSE: G) (FSE: 11B) has closed on its nonbrokered private placement, a move that resulted in gross proceeds of approximately C$17 million for the company. Announced earlier, the placement included 7.56 million units,…
-
MissionIRNewsBreaks – Ideanomics (NASDAQ: IDEX) Enters Investment Agreement with Energica Motor Company S.p.A
Ideanomics (NASDAQ: IDEX), on March 3, 2021, entered into an investment agreement with Energica Motor Company S.p.A pursuant to which Ideanomics invested Euro 10,909,091 for 6,128,703 ordinary shares of Energica at a subscription price of…
-
MissionIRNewsBreaks – Why Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Is ‘One to Watch’
Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) is a producer of silver and base metals with precious metal exploration and development projects in Mexico, Idaho and Germany. Since its 1987 founding, the company…
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Leveraging AI, Proprietary Database to Improve Outcomes for Patients of Today and Tomorrow
Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company focused on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has been a forerunner in the field, helping oncologists individualize cancer treatment…
-
MissionIRNewsBreaks – VistaGen Therapeutics Inc.’s (NASDAQ: VTGN) Pipeline Holds Potential to Go Beyond Standard of Care for Anxiety, Depression
VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing a new generation of medications that go beyond the standard of care for anxiety and depression. A recent article discussing this reads, “Depression and…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Talks About Recent Formation of Food Industry Consortium in “Emerging Technology Insider” Video
Pressure BioSciences (OTCQB: PBIO) (“PBI”) founder, president and CEO Ric Schumacher was a guest on a recent episode of “Emerging Technology Insider,” which regularly releases video conversations with management of technology companies with business or…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Upcoming H.C. Wainwright Global Life Sciences Conference
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the company’s CEO, John Climaco, will…
-
SRAX Inc.’s (NASDAQ: SRAX) Sequire Investor Analytics Platform Helps Public Companies Monitor Investors Amid Record-Breaking Microcap Trading Activity
Microcap stocks outperforming 2020 record highs, currently trading at 40% above 200-day moving average SRAX’s Sequire SaaS platform provides public companies with tools to monitor trading activity, provides actionable insights for use in marketing campaigns…
-
Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives
Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space Acquisition results in Cybin…
-
Brain Scientific (BRSF) Developing State-of-the-Art AI Diagnostic Analytics
BRSF working to improve diagnostics by leveraging AI and machine learning Cloud-based infrastructure, AI-assisted diagnostic analysis is in development phase Brain Scientific creating long-term monitoring capabilities that leads to collection of essential biomarkers Brain Scientific…
-
MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Unveils New Website, Completion of Corporate Rebranding Strategy
XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, announced that it has completed its corporate rebranding efforts. Those efforts included the…
-
MissionIRNewsBreaks – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) Joins Investee in Support of City’s Ban of New Gas Stations
Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, and its investee company PowerTap Hydrogen Fueling Corp. have announced their support for a recent announcement made by the city of Petaluma, California.…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Duos Technologies Group, Inc. (NASDAQ: DUOT) Prices $65M Public Offering to Advance Edge Data Center Expansion
- MissionIRNewsBreaks – ClearThink 1 Acquisition Corp. (NASDAQ: CTAAU) Closes $125M Initial Public Offering
- MissionIRNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Reports Surge in Institutional Ownership as Platform Expansion Accelerates
- Forward Industries Inc. (NASDAQ: FWDI) Executes the Company’s Solana Treasury Strategy to Build on a Successful 2026 Fiscal Q1
- MissionIRNewsBreaks – Olenox Industries (NASDAQ: OLOX) Launches 2026 Drilling Program, Targets 1,000 BOE per Day by Year-End